
The AABB Foundation Early-Career Scientific Research Grant Program supports investigator-initiated original research across all aspects of blood banking, transfusion medicine and biotherapies. These grants have been instrumental in advancing the Foundation's mission of making transfusion medicine and biotherapies safe, available and effective on a global scale.
Grant applications are assessed based on scientific merit, relevance to and impact on the field, appropriateness to the funding scope and the potential to yield meaningful data. Throughout the years, numerous grant recipients have become leaders in the field, with their innovative research resulting in scientific and medical advances that save lives and improve the health of millions of patients and donors globally.
Investigators on a trajectory toward research independence are strongly encouraged to apply for these grants to advance their scientific pursuits. Applications for the 2026 cycle will be accepted until Dec. 1, 2025.
To learn more about the grant application process, see the information on frequently asked questions below and consider submitting your application for the 2026 cycle.
All grant applications will be reviewed by the AABB Foundation Scientific Research Grants Review Committee (GRC). This committee meets once a year to select grant recipients. Outside reviewers may be consulted at the discretion of the committee. The AABB Foundation Board of Directors must approve the GRC’s recommendations before official awards may be made. Grants are announced in June and funds are disbursed in July.
A confidential critique review sheet of the proposed grant project that summarizes the GRC’s comments is provided to all applicants. AABB and the Foundation reserve the right to list the grant recipients in publications, including the title, principal investigator and amount of funding.
An applicant must be a doctor (MD or PhD), medical technologist, transfusion medicine or biotherapies professional. All applicants will be considered regardless of age, race, gender, national origin or religion.
The Foundation accepts early-career applicants worldwide. Early-career is defined as follows:
The AABB Foundation’s intention is to fund researchers on a path toward research independence. No candidate is eligible to receive more than one AABB Foundation early-career Scientific Research Grant in the course of their career.
Individuals with questions on the application process are invited to contact the AABB Foundation at foundation@aabb.org. For more information, visit aabb.org/grants.
Many AABB Foundation early-career grant recipients have become leaders in their field and are recognized in the Foundation’s Hall of Fame. Below, just a few provide their thoughts on how receiving a Foundation grant helped their career.
Moritz Stolla, MD, PhDDirector, Platelet Transfusion Research Associate Member, Bloodworks NW Research Institute Associate Medical Director, Bloodworks NW, Blood Transfusion Service Associate Professor, Div. of Hematology, Dept. of Medicine, University of Washington School of Medicine
“The funding from the AABB Foundation was an incredible help when I started my independent lab. The AABB foundation award was the first external one I received, a critical step for every junior investigator. Soon, other awards followed, but the AABB award was essential to get launched.”
Chance John Luckey, MD, PhDAssociate Professor of Pathology
Medical Director of Cell Therapy Collections and Processing
University of Virginia School of Medicine
"AABB Foundation funding provided invaluable opportunities for me to interact with like-minded clinicians and scientists in the field. The connections I made through the AABB Foundation have not only led to a host of fruitful scientific collaborations supported by the NIH, but more importantly provided some of my closest friends."
Brian R. Smith, MDDeputy Dean for Clinical and Translational Research
Co-Director, Yale Center for Clinical Investigation
Professor and Chair of Laboratory Medicine
Professor of Biomedical Engineering, Int Medicine, Pediatrics
Yale University School of Medicine
"The AABB Foundation was instrumental in moving my research focus to translational projects designed to positively impact ameliorating the complications of transfusion and improve cellular therapy. Very importantly, it also provided key opportunities to co-mingle clinician-scientists, clinicians, and non-clinician investigators that encouraged cross-disciplinary collaborations critical to moving Transfusion Medicine forward."
Cheryl Lobo, PhDHead, Blood-Borne Parasites
Lindsley Kimball Research Institute
New York Blood Center
“Being recognized as an AABB Foundation awardee supported my laboratory both financially and professionally. Not only did the grant monies focus my work on parasite biology in a translational research direction but also allowed me to forge strong connections with a collaborative network of transfusion medicine researchers.”
PREVIOUS STORY
The Role of MentorshipBACK TO ISSUE
October 2025NEXT STORY
Making the Most of the Meeting
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
